Make us your home page
Instagram

Shkreli invokes the Fifth Amendment in House appearance

Martin Shkreli, the former chief executive of Turing Pharmaceuticals, reacts as Rep. Elijah Cummings, D-Md., speaks during a hearing before the House Oversight and Government Reform Committee on Thursday in Washington.

New York Times

Martin Shkreli, the former chief executive of Turing Pharmaceuticals, reacts as Rep. Elijah Cummings, D-Md., speaks during a hearing before the House Oversight and Government Reform Committee on Thursday in Washington.

In a testy exchange with lawmakers, Martin Shkreli declined to testify before a House committee Thursday about his actions in increasing the price of a decades-old drug fiftyfold overnight.

Shkreli, who left Turing Pharmaceuticals, the drug company he started, after being indicted on federal securities fraud charges in December, repeatedly exercised his Fifth Amendment right to avoid self-incrimination, angering various members of the House Committee on Oversight and Government Reform.

"I don't think I've ever seen the committee treated with such contempt," Rep. John Mica, R-Fla., said after Shkreli was excused and left the room.

Shkreli did answer "yes'' when Rep. Trey Gowdy, R-S.C., asked him if he had pronounced his name properly.

The theatrics surrounding Shkreli's appearance, which included his smirking at some remarks by committee members and calling them "imbeciles" on Twitter after he left the hearing, overshadowed the discussion about huge overnight increases in the prices of old drugs by Turing and another company, Valeant Pharmaceuticals International.

Under Shkreli, Turing acquired the rights to Daraprim, a 62-year-old drug for a parasitic infection, and raised the price fiftyfold to $750 a pill.

Valeant has increased the price of numerous old drugs, but the House committee has focused on two heart drugs, Isuprel and Nitropress.

Howard B. Schiller, interim CEO of Valeant, rationalized the substantial increases in the prices of the two heart drugs by arguing that the company would merely be taking money from hospitals, not hurting patients. At the hearing, Schiller said the company now recognized that it had been too aggressive on certain pricing decisions and acknowledged public concern.

Shkreli invokes the Fifth Amendment in House appearance 02/04/16 [Last modified: Thursday, February 4, 2016 7:56pm]
Photo reprints | Article reprints

Copyright: For copyright information, please check with the distributor of this item, New York Times.
    

Join the discussion: Click to view comments, add yours

Loading...
  1. 'Road to Nowhere' is back: Next phase of Suncoast Parkway coming

    Roads

    Despite intense public opposition and dubious traffic projections, the Florida Department of Transportation has announced that construction of the toll road known as "Suncoast 2" is expected to start in early 2018.

    The Suncoast Parkway ends at U.S. 98 just south of Citrus County. For years residents have opposed extending the toll road, a project dubbed the "Suncoast 2" into Citrus County. But state officials recently announced that the Suncoast 2 should start construction in early 2018. [Stephen J. Coddington  |  TIMES]
  2. A sports rout on Wall Street

    Retail

    NEW YORK — Sporting goods retailers can't shake their losing streak.

  3. Grocery chain Aldi hosting hiring event in Brandon Aug. 24

    Retail

    BRANDON — German grocery chain Aldi is holding a hiring event for its Brandon store Aug. 24. It is looking to fill store associate, shift manager and manager trainee positions.

  4. Lightning owner Jeff Vinik backs film company pursuing global blockbusters

    Corporate

    TAMPA — Jeff Vinik's latest investment might be coming to a theater near you.

    Jeff Vinik, Tampa Bay Lightning owner, invested in a new movie company looking to appeal to a global audience. | [Times file photo]
  5. Trigaux: Look to new Inc. 5000 rankings for Tampa Bay's future heavyweights

    Business

    There's a whole lotta fast-growing private companies here in Tampa Bay. Odds are good you have not heard of most of them.

    Yet.

    Kyle Taylor, CEO and founder of The Penny Hoarder, fills a glass for his employees this past Wednesday as the young St. Petersburg personal advice business celebrates its landing at No. 25 on the 2017 Inc. 5000 list of the fastest growing private companies in the country. Taylor, still in his 20s, wins kudos from executive editor Alexis Grant for keeping the firm's culture innovative. The business ranked No. 32 last year. [DIRK SHADD   |   Times]